Jennifer T. Feldman, MBA, HTL (ASCP), QIHC, is a visionary healthcare business development leader with over 23 years of experience in oncology diagnostics, medical devices, and biotechnology. She has a proven track record of driving strategic partnerships, advancing innovative technologies, and optimizing commercial success in the healthcare industry. Jennifer’s expertise spans clinical pathology, research-use-only applications, and companion diagnostics, making her a key player in transforming patient care. With an MBA in International Business and certifications in histotechnology and immunohistochemistry, she seamlessly blends technical proficiency with business acumen. A sought-after speaker and industry expert, Jennifer is passionate about leveraging her knowledge and leadership to foster innovation, improve healthcare outcomes, and contribute to the future of medical advancements.

Diana Rollins is a dynamic leader in medical device sales and business development, with a proven track record of launching innovative healthcare technologies and driving market adoption. With over two decades of experience, she has successfully introduced cutting-edge products in cardiovascular surgery, vascular intervention, and remote patient monitoring, working closely with physicians, hospital executives, and outpatient facilities to ensure seamless integration. Her expertise in sales strategy, health insurance reimbursement, and value analysis has led to significant revenue growth and successful acquisitions within the industry. A lifelong learner with a background in public health and an MBA, Diana continuously refines her skills in strategic selling and healthcare innovation. Her passion for improving patient outcomes and her ability to navigate complex healthcare systems make her an invaluable force in the medical technology space.